Abstract Streptococcus pyogenes (Group A Streptococcus; GAS) is exquisitely adapted to
the human host, resulting in asymptomatic infection, pharyngitis, pyoderma, scarlet fever or …

Streptococcus pyogenes, also known as group A Streptococcus (GAS), causes mild human
infections such as pharyngitis and impetigo and serious infections such as necrotizing …

The increasing prevalence of antibiotic-resistant bacteria portends an impending
postantibiotic age, characterized by diminishing efficacy of common antibiotics and routine …

The composition of the Gram-positive cell wall is typically described as containing
peptidoglycan, proteins and essential secondary cell wall structures called teichoic acids …

Group A streptococci (GAS) are genetically diverse. Determination of strain features can
reveal associations with disease and resistance and assist in vaccine formulation. We …

Streptococcus pyogenes (or Group A Streptococcus, GAS) is a Gram-positive human
pathogen responsible for a diverse array of superficial, invasive and immune-related …

The identification of the molecular events responsible for strain emergence, enhanced
virulence, and epidemicity has been a long-pursued goal in infectious diseases research. A …

ABSTRACT Group A Streptococcus (GAS) genotype emm 89 is increasingly recognized as a
leading cause of disease worldwide, yet factors that underlie the success of this emm type …

Streptococcus pyogenes is a globally prominent human-specific pathogen responsible for
an enormous burden of human illnesses, including> 600 million pharyngeal and> 100 …

Strains of emm89 Streptococcus pyogenes have become one of the major causes of
invasive infections worldwide in the last 10 years. We recently sequenced the genome of …